Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Nutting Insider Profile
4 Followers
Christopher Nutting, Director at Advanced Oncotherapy, holds 217.32K shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Christopher Nutting Bought 202,500p shares of Advanced Oncotherapy on May 11, 2017 for an estimated value of 49.96K.
Christopher Nutting Advanced Oncotherapy (AVO)Director
Advanced Oncotherapy (AVO)
Director
Ranked #10,635 out of 98,042 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+275.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Christopher Nutting does not currently own shares as a corporate insider.
A breakdown of Christopher Nutting's holdings
Insider Roles
Christopher Nutting does not currently hold a role as a corporate insider.
Roles that Christopher Nutting holds in companies
Most Profitable Insider Trade
Stock:
Advanced Oncotherapy
(AVO)
(AVO)
Rating:Informative Buy
Date:Apr 17, 2014 - Apr 17, 2015
Return:+418.10%
The most profitable trade made by Christopher Nutting
Christopher Nutting's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Nutting's performance on stock
You May Also Like
Christopher Nutting insider profile FAQ
What is the percentage of profitable transactions made by Christopher Nutting?
The percentage of profitable transactions made by Christopher Nutting is 100%.
What is the average return per transaction made by Christopher Nutting?
The average return per transaction made by Christopher Nutting is 275.50%.
What stocks does Christopher Nutting hold?
Christopher Nutting holds: GB:AVO stocks.
What was Christopher Nutting’s latest transaction?
Christopher Nutting latest transaction was an Informative Buy of 49.96K.
What was Christopher Nutting's most profitable transaction?
Christopher Nutting’s most profitable transaction was an Informative Buy of GB:AVO stock on April 17, 2014. The return on the trade was 418.10%.
What is Christopher Nutting's role in Advanced Oncotherapy?
Christopher Nutting's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.